liraglutide
Showing 1 - 25 of 281
Polycystic Ovary Trial in Bani Suwayf (liraglutide, Metformin)
Not yet recruiting
- Polycystic Ovary
- liraglutide
- Metformin
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university Hospital
Jul 28, 2023
Obesity, Childhood, Neural Development Trial in New Haven (Liraglutide)
Completed
- Obesity, Childhood
- Neural Development
- Liraglutide
-
New Haven, ConnecticutYale University
Dec 5, 2022
Parkinson Disease Trial in Los Angeles (Liraglutide, Placebo)
Completed
- Parkinson Disease
- Liraglutide
- Placebo
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Oct 27, 2022
Obesity, Status Post Sleeve Gastrectomy Trial run by the NICHD (Liraglutide)
Recruiting
- Obesity
- Status Post Sleeve Gastrectomy
- Liraglutide
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 16, 2022
Diabetes, Type 1 Trial in Monterrey (Liraglutide)
Recruiting
- Diabetes Mellitus, Type 1
- Liraglutide
-
Monterrey, Nuevo León, MexicoCentro Médico Nacional del Noreste Hospital de Especialidades UM
Jul 19, 2022
Growth Hormone Deficiency, Healthy Trial in New York (growth hormone and lirglutide, growth hormone, liraglutide)
Not yet recruiting
- Growth Hormone Deficiency
- Healthy
- growth hormone and lirglutide
- +3 more
-
New York, New YorkNeuroendocrine Unit and Pituitary Center, Columbia University Ir
Dec 27, 2022
Obesity Trial in Rochester (Liraglutide, Placebo)
Completed
- Obesity
- Liraglutide
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
May 27, 2022
Obese, Overweight Trial in Shanghai (Liraglutide, Placebo)
Active, not recruiting
- Obese
- Overweight
- Liraglutide
- Placebo
-
Shanghai, ChinaZhongshan Hosital, Fudan University
Apr 16, 2022
Type 2 Diabetes Trial in Chongqing (Liraglutide, Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation),
Completed
- Type 2 Diabetes Mellitus
- Liraglutide
- Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation), Thiazolidinediones, α-Glucosidase inhibitors, and Glinides
-
Chongqing, Chongqing, ChinaThe third hospital affiliated to the Third Military Medical Univ
Apr 30, 2022
Type 1 Diabetes Trial in Buffalo (Liraglutide)
Active, not recruiting
- Type 1 Diabetes
- Liraglutide
-
Buffalo, New YorkUBMD Pediatrics, Division of Pediatric Endocrinology
Mar 7, 2022
Type 2 Diabetes Trial in Helsinki (Liraglutide, Placebo)
Completed
- Type 2 Diabetes
- Liraglutide
- Placebo
-
Helsinki, FinlandHelsinki University Central Hospital
Apr 11, 2022
Type 2 Diabetes Treated With Insulin, Obesity, Adolescent Obesity Trial in Lahore (Dulaglutide, Liraglutide)
Completed
- Type 2 Diabetes Treated With Insulin
- +2 more
- Dulaglutide
- Liraglutide
-
Lahore, Punjab, PakistanZainab Khan
Mar 11, 2022
Diabete Type 2 Trial (Liraglutide, Placebo)
Not yet recruiting
- Diabete Type 2
- Liraglutide
- Placebo
- (no location specified)
Feb 24, 2022
Bipolar Disorder, Obesity Trial in Mason (LIRAGLUTIDE, Placebo)
Active, not recruiting
- Bipolar Disorder
- Obesity
- LIRAGLUTIDE
- Placebo
-
Mason, OhioLindner Center of HOPE
May 24, 2022
Ischemic Stroke, Transient Ischemic Attack, Type 2 Diabetes Trial in Guangzhou (Liraglutide)
Recruiting
- Ischemic Stroke
- +2 more
- Liraglutide
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Jinan University
Mar 17, 2022
Type2 Diabetes Trial in Charlottesville (Exercise, Liraglutide)
Recruiting
- Type2 Diabetes
- Exercise
- Liraglutide
-
Charlottesville, VirginiaUniversity of Virginia
Mar 7, 2022
Diabetes, Type 2, Hemodialysis, Obese Trial in Paris, Saint-Ouen (Liraglutide)
Recruiting
- Diabetes Mellitus, Type 2
- +2 more
- Liraglutide
-
Paris, Groupe Hospitalier Paris Saint-Joseph, France
- +3 more
Mar 30, 2022
Healthy Trial in Singapore (LY3537021, Liraglutide, Placebo)
Active, not recruiting
- Healthy
- LY3537021
- +2 more
-
Singapore, SingaporeLilly Centre for Clinical Pharmacology
Nov 22, 2022
Overweight, Obesity Trial in United States (Semaglutide, Placebo (semaglutide), Liraglutide)
Obesity, Visceral, Cardiovascular Diseases, Fat Disorder Trial in Dallas (Liraglutide, Placebo)
Completed
- Obesity, Visceral
- +2 more
- Liraglutide
- Placebo
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Oct 20, 2021
Harmonizing RCT-Duplicate Emulations In A Real World Replication
Completed
- Type 2 Diabetes Mellitus
- Canagliflozin
- +4 more
-
Gothenburg, SwedenResearch Site
Oct 23, 2023
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Santa Monica, California
- +31 more
Nov 18, 2022
Obesity Trial in Changsha (Liraglutide, Liraglutide;metformin)
Withdrawn
- Obesity
- Liraglutide
- Liraglutide;metformin
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Apr 8, 2021
Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Liraglutide, Empagliflozin, Linagliptin)
Recruiting
- Type 2 Diabetes Mellitus
- Mild Cognitive Impairment
- Liraglutide
- +2 more
-
Nanjing, Jiangsu, China
- +1 more
Mar 28, 2022